✦ LIBER ✦

Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia

✍ Scribed by Wu, Eric Q.; Guerin, Annie; Yu, Andrew P.; Bollu, Vamsi K.; Guo, Amy; Griffin, James D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dasatinib and nilotinib in first-line tr

✍ Jame Abraham 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 77 KB

A retrospective analysis of therapy adhe

✍ Guérin, Annie; Chen, Lei; Wu, Eric Q.; Ponce de Leon, Diego; Griffin, James D. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 174 KB

The Economic Burden Of Dasatinib And Nil

✍ Pokras, S.M.; Divino, V.; Ferrufino, C.P.; R.J.G., Arnold; Huang, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN47 COMPARISON OF HEALTH CARE RESOURCE

✍ EQ Wu; V Bollu; A Guo; A Guerin; M Tsaneva; D Williams; JD Griffin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN60 Cost Effectiveness of Nilotinib, D

✍ Romero Martin, R.M.; Alvis Nelson, A.N.; De los Ríos Magalí, D.L.R.M.; Chávez Di 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Comparative efficacy of nilotinib and da

✍ Signorovitch, James E.; Wu, Eric Q.; Betts, Keith A.; Parikh, Kejal; Kantor, Eva 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 190 KB